Search Advanced

AIMS Medical Science

2020, Volume 7, Issue 2: 69-78. doi: 10.3934/medsci.2020006
Previous Article Next Article
Research article

Frequency and risk factors of polypharmacy and drug interactions among patients in general intensive care unit of Golestan Hospital, Ahvaz, southwest of Iran

  • 1.
    School of Pharmacy, Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  • 2.
    Anaesthesiologist and fellowship of Critical Care Medicine. Golestan Hospital; Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  • 3.
    Department of Clinical Pharmacy, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  • 4.
    Department of Clinical Pharmacy, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  • Received: 23 February 2020 Accepted: 11 June 2020 Published: 23 June 2020

  • Citation: Mobina Tahmasebivand, Farhad Soltani, Leila Kouti, Mandana Izadpanah. Frequency and risk factors of polypharmacy and drug interactions among patients in general intensive care unit of Golestan Hospital, Ahvaz, southwest of Iran[J]. AIMS Medical Science, 2020, 7(2): 69-78. doi: 10.3934/medsci.2020006

    Related Papers:



  • 加载中

    Acknowledgments


    This article is extracted from Mobina Tahmasebivand's thesis with registration no. B-97046 for a Pharm. D degree of Ahvaz Jundishapur University of Medical Sciences. The authors would like to thank Dr. Fakher Rahim for his helpful advice and constructive comments.

    Conflict of interest


    All authors declare no conflicts of interest in this paper.

    [1] Pea F, Furlanut M (2001) Pharmacokinetic aspects of treating infections in the intensive care unit. Focus on drug interactions. Clin Pharmacokinet 40: 833-868.
    [2] Dorado P, Peñas-LLedó E, Gonzalez A, et al. (2007) Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9* 3 allele. Fundam Clin Pharmacol 21: 451-453.
    [3] Ahmadi B, Alimohamadian M, Mahmoodi M, et al. (2006) Polypharmacy among older adults in Tehran. Tehran Univ Med J 64: 55-64.
    [4] Michalik C, Matusik P, Nowak J, et al. (2013) Heart failure, comorbidities, and polypharmacy among elderly nursing home residents. Pol Arch Med Wewn 123: 170-175.
    [5] Juurlink D, Mamdani MK, Kopp A, et al. (2003) Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289: 1652-1658.
    [6] Cruciol-Souza JM, Thomson JC (2006) Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci 9: 427-433.
    [7] Rodriguez-Monguio R, Otero MJ, Rovira J (2003) Assessing the economic impact of adverse drug effects. Pharmacoeconomics 21: 623-650.
    [8] Spina E, De Leon J (2007) Metabolic drug interactions with newer antipsychotics: A comparative review. Basic Clin Pharmacol Toxicol 100: 4-22.
    [9] Åstrand E, Åstrand B, Antonov K, et al. (2007) Potential drug interactions during a three-decade study period: A cross-sectional study of a prescription register. Eur J Clin Pharmacol 63: 851-859.
    [10] Kwan TC, Wahba W, Wildeman R (1979) Drug interactions: A retrospective study of its epidemiology, clinical significance and influence upon hospitalization. Can J Hosp Pharm 32: 12-16.
    [11] Masnoon N, Shakib S, Kalisch-Ellett L, et al. (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17: 230.
    [12] Fontes KE Common ED Medication Errors: Polypharmacy (2017). Available from: http://www.emdocs.net/common-ed-medication-errors-polypharmacy/
    [13] Dai D, Feinstein JA, Morrison W, et al. (2016) Epidemiology of polypharmacy and potential drug-drug interactions among pediatric patients in intensive care units of US Children's Hospitals. Pediatr Crit Care Med 17: e218-228.
    [14] Khandeparkar A, Rataboli PV (2017) A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College. Perspect Clin Res 8: 180-186.
    [15] Oğlu MGI, Küçükibrahimoğlu E, Karaalp A, et al. (2016) Potential drug? drug interactions in a medical intensive care unit of a university hospital. Turk J Med Sci 46: 812-819.
    [16] Ismail M, Khan F, Noor S, et al. (2016) Potential drug–drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan. Int J Clin Pharm 38: 1052-1056.
    [17] De Almeida SM, Gama CS, Akamine N (2007) Prevalence and classification of drug-drug interactions in intensive care patients. Einstein 5: 347-351.
    [18] Abbasi Nazari M, Khanzadeh Moqhadam N (2010) Evaluation of pharmacokinetic drug interactions in prescriptions of intensive care unit (ICU) in a teaching hospital. Iranian J Pharm Res : 215-218.
    [19] Lima REF, Cassiani SHDB (2009) Potential drug interactions in intensive care patients at a teaching hospital. Rev Lat Am Enfermagem 17: 222-227.
    [20] Papadopoulos J, Smithburger PL (2010) Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations. Crit Care Med 38: S126-S135.
    [21] Hammes JA, Pfuetzenreiter F, Silveira Fd, et al. (2008) Prevalência de potenciais interações medicamentosas droga-droga em unidades de terapia intensiva. Revista Brasileira de Terapia Intensiva 20: 349-354.
    [22] Dianati M, Shojaegharebag GA, Mesdaghinia A, et al. (2015) Polypharmacy and its related factors among the elderly population in Kashan, Iran during 2011–2012. KAUMS J (FEYZ) 18: 578-584.
    [23] Murtaza G, Khan MYG, Azhara S, et al. (2015) Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharm J 24: 220-225.
    [24] Rafieii H, Ranjbar H, Arab N, et al. (2012) The prevalence of potential drug interactions in intensive care units. Iran J Crit Care Nurs 4.
    [25] Torkashvand M, Esnaashari F, Mehrpoya M, et al. (2018) Evaluation of potential drug interactions and related factors in patients admitted in department of cardiology of farshchian heart hospital of hamadan. J Clin Med 25: 105-111.
  • Reader Comments
  • © 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
AIMS Medical Science
0.4

Metrics

Article views(3887) PDF downloads(327) Cited by(1)

Preview PDF
Download XML
Export Citation
Article outline

Figures and Tables

Tables(7)

Other Articles By Authors

Related pages

Tools

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog